| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,031 | 2,282 | 1,953 | 2,084 | | Cost of Revenue | 1,630 | 1,647 | 1,662 | 1,689 | | | Gross Profit | 400 | 635 | 291 | 395 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 932 | 769 | 772 | 1,038 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 349 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (532) | (134) | (481) | (643) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | (125) | (67) | (4,384) | | Earnings Before Interest And Taxes | (889) | (259) | (548) | (5,027) | | Interest Expense | (256) | 298 | 267 | 328 | | Income Before Tax | (633) | (557) | (815) | (5,355) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (633) | (557) | (815) | (5,355) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,202 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (633) | (557) | (815) | (4,153) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($633) | ($557) | ($815) | ($4,153) |
|
0.08% Nasdaq 
0.14%
Income Statement
